A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)

A Multicenter, Double-Blind, Comparative Study of MK0991 (Caspofungin) Versus Micafungin in Adult Japanese Patients With Deep-seated Candida or Aspergillus Infections

The purpose of this study is to investigate the safety and efficacy of MK0991 in patients with deep-seated mycoses.

Inclusion Criteria:

• Japanese Patients In Whom A Causative Fungus Is Detected Before Treatment With The Study Drug Or Patients With Strongly Suspected Deep-Seated Fungal Infection Due To Candida species (Spp.) Or Aspergillus Spp.

Exclusion Criteria:

• Patients With Mycoses Other Than Ones Due To Candida Spp. Or Aspergillus Spp.
• Patients Who Will Receive Other Systemic Antifungal Agents For The First Time In Screening Period.